• UCLA Health
  • myUCLAhealth
  • School of Medicine
UCLA Pathology & Laboratory Medicine

UCLA Pathology & Laboratory Medicine

UCLA Pathology & Laboratory Medicine
  • About Us
    • Chair's Message
    • Leadership
    • Administration / Contacts
    • Locations
    • Licensure & Accreditation
    • Path & Lab News
    • Wellness
    • Giving to Pathology
  • Clinical Services
    • Anatomic Pathology
    • Laboratory Medicine
    • Clinical Genomics Center
    • Immunogenetics Center
    • International Collaborations
    • Olympic Lab
    • Outreach
    • Center for Telepathology and Digital Pathology
    • Quality Improvement and Clinical Innovation
  • Education
    • Pathology Grand Rounds
    • Medical & Dental Education
    • Residency Program
    • Fellowship Programs
    • Research Training
    • Allied Health Training
  • Research Enterprise
    • Infrastructure
    • Collaboration
    • Research Faculty
    • Research Training
    • Funding Opportunities
    • Research Assistants/Associates
  • Research Services
    • Brain Tumor Translational Resource (BTTR)
    • Immunogenetics (UIC)
    • Immune Assessment Core (IAC)
    • Pathology Research Portal (PRP)
    • Translational Pathology Core Laboratory (TPCL)
    • Technology Center for Genomics & Bioinformatics (TCGB)
  • Quick Links
    • Business Office
    • Faculty/Staff Resources
    • Intranet
    • Locations
    • Path IT Service Now
    • Submit Website Changes
  • Meet Our Faculty
    • Primary
    • Affiliates
    • Joint Appointment
    • MSP
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Pathology & Laboratory Medicine

Immune Assessment Core (IAC)

Immune Assessment Core (IAC)

Immune Assessment Core (IAC)

  • Services and Pricing
    • Flow Cytometry Based Immune Assessment
    • Immunoassays
    • Real-Time Cell Lysis and Cell Proliferation
  • Resources
  • How to Use
  • Contact Us
  • Services and Pricing
  • Resources
  • How to Use
  • Contact Us
  1. Home
  2. Research Services
  3. Immune Assessment Core (IAC)

Immune Assessment Core (IAC)



IAC_2016-94.jpg

ABOUT US

The Immune Assessment Core (IAC) is a CLIA certified laboratory (#045D0642433) providing comprehensive immunological testing services for basic, clinical, and translational studies. The IAC provides both standardized and customized multi-parameter flow cytometry, multiplexed immunoassays, ultra-sensitive immunoassay technology (Simoa Quanterix), and cellular immune function assays to evaluate the innate and adaptive immune status of study subjects. The Core uses high-throughput technologies to maximize data output using small sample volumes. We work closely with our clients to assist with data analysis and interpretation to maximize knowledge gained.

Validated tests include comprehensive immunophenotyping panels, multiplexed cytokine/chemokine detection in body fluids or culture supernatants, single molecule assays (Simoa), several ELISA assays, allo- and virus-specific T cell activation, T and B cell proliferation to antigens and mitogens, NK cell cytotoxicity, and granulocyte/monocyte oxidative burst. These assays can be used to aid the diagnosis of primary immunodeficiency and for immune monitoring purposes. In addition to our various validated assays, the core performs customized assay development to meet the investigators’ needs.

The IAC is actively involved in projects aimed at standardizing immune assessment assays, including the NIH CTOT harmonization consortium and the FOCIS/NIH sponsored HIPC validation project. These consortia are focused on developing and implementing standardized protocols for testing and data analysis.

CURRENT EVENTS

Kyle Valiente Almendras was recruited as the new SRA in the Immune Assessment Core

RECENT PUBLICATIONS

Cappelletti M, Presicce P, Feiyang M, Senthamaraikannan P, Miller LA, Pellegrini M, Sim MS, Jobe AH, Divanovic S, Way SS, Chougnet CA, Kallapur SG. The induction of preterm labor in rhesus macaques is determined by the strength of immune response to intrauterine infection. PLoS Biol. 2021 Sep 8;19(9):e3001385. doi: 10.1371/journal.pbio.3001385. PMID: 34495952; PMCID: PMC8452070.

Chang YL, Rossetti M, Gjertson DW, Rubbi L, Thompson M, Montoya DJ, Morselli M, Ruffin F, Hoffmann A, Pellegrini M, Fowler VG Jr, Yeaman MR, Reed EF; with the MRSA Systems Immunology Group. Human DNA methylation signatures differentiate persistent from resolving MRSA bacteremia. Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2000663118. doi: 10.1073/pnas.2000663118. PMID: 33649198; PMCID: PMC7958259.

Sosa RA, Terry AQ, Kaldas FM, Jin YP, Rossetti M, Ito T, Li F, Ahn RS, Naini BV, Groysberg VM, Zheng Y, Aziz A, Nevarez-Mejia J, Zarrinpar A, Busuttil RW, Gjertson DW, Kupiec-Weglinski JW, Reed EF. Disulfide High-Mobility Group Box 1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation. Hepatology. 2021 Mar;73(3):1158-1175. doi: 10.1002/hep.31324. Epub 2020 Oct 30. PMID: 32426849.

Facebook Twitter Instagram Youtube LinkedIn
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap